Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Hematologic Neoplasms 2Anemia 2Red Blood Cells Transfusion 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 7fludarabine 6Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 4Antilymphocyte Serum 4Alemtuzumab 3Thiotepa 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Clofarabine 2treosulfan 1thymoglobulin 1posaconazole 1eltrombopag 1X-Rays 1Therapeutics 1Specimen Handling 1Sirolimus 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Methadone 1Hydromorphone 1Genetic Counseling 1Erythrocyte Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bone Marrow Failure Disorders × Erythrocyte Transfusion × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡